Free Trial

Galectin Therapeutics (GALT) Insider Trading & Ownership

Galectin Therapeutics logo
$2.21 0.00 (0.00%)
As of 11:45 AM Eastern

Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
52.60%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$6.34K
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$4.61M
Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GALT Insider Buying and Selling by Quarter

Galectin Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/6/2026
Kary Eldred
Director
Buy300$2.70$810.00  
1/6/2026
Jack W Callicutt
CFO
Sell20,354$3.67$74,699.18  
1/6/2026
Joel Lewis
CEO
Sell37,698$3.58$134,958.84  
1/6/2026
Khurram Jamil
Insider
Sell21,446$3.65$78,277.90  
1/5/2026
Jack W Callicutt
CFO
Sell25,732$3.90$100,354.80  
1/5/2026
Joel Lewis
CEO
Sell27,731$3.91$108,428.21  
1/5/2026
Khurram Jamil
Insider
Sell25,499$3.90$99,446.10  
1/2/2026
Jack W Callicutt
CFO
Sell13,914$4.20$58,438.80  
1/2/2026
Joel Lewis
CEO
Sell18,571$4.20$77,998.20  
1/2/2026
Khurram Jamil
Insider
Sell13,055$4.20$54,831.00  
12/23/2025
Kary Eldred
Director
Buy700$3.73$2,611.00  
12/17/2025
Harold H Shlevin
Director
Sell24,499$7.04$172,472.96  
12/17/2025
Joel Lewis
CEO
Sell7,829$7.06$55,272.74  
12/17/2025
Khurram Jamil
Insider
Sell19,442$7.04$136,871.68  
12/16/2025
Fund L.P. 10X
Major Shareholder
Sell30,681$6.66$204,335.46  
12/9/2025
Harold H Shlevin
Director
Sell16,790$6.27$105,273.30  
12/8/2025
Harold H Shlevin
Director
Sell159,000$5.98$950,820.00  
12/3/2025
Fund L.P. 10X
Major Shareholder
Sell120,000$5.73$687,600.00  
12/2/2025
Fund L.P. 10X
Major Shareholder
Sell30,000$5.47$164,100.00  
11/13/2025
Khurram Jamil
Insider
Sell121,117$5.47$662,509.99  
11/5/2025
Joel Lewis
CEO
Sell200$6.00$1,200.00  
11/4/2025
Jack W Callicutt
CFO
Sell28,629$6.07$173,778.03  
11/4/2025
Joel Lewis
CEO
Sell14,420$6.07$87,529.40  
11/3/2025
Jack W Callicutt
CFO
Sell3,810$6.01$22,898.10  
11/3/2025
Joel Lewis
CEO
Sell1,300$6.01$7,813.00  
10/22/2025
Fund L.P. 10X
Major Shareholder
Sell50,000$4.94$247,000.00  
9/12/2025
Jack W Callicutt
CFO
Sell8,706$6.44$56,066.64  
9/12/2025
Joel Lewis
CEO
Sell14,000$6.36$89,040.00  
7/21/2025
Kary Eldred
Director
Buy1,000$2.92$2,920.00  
(Data available from 1/1/2013 forward)

GALT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Galectin Therapeutics includes Fund L.P. 10X, Harold H Shlevin, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, Khurram Jamil, and Richard A Jr. Zordani. Learn more on insiders at GALT.

52.60% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings.

The following insiders have purchased GALT shares in the last 24 months: Harold H Shlevin ($7,540.00), Kary Eldred ($7,641.00), Kevin D Freeman ($13,500.00), and Richard A Jr. Zordani ($12,245.70).

Insiders have purchased a total of 25,759 GALT shares in the last 24 months for a total of $40,926.70 bought.

The following insiders have sold GALT shares in the last 24 months: Fund L.P. 10X ($1,303,035.46), Harold H Shlevin ($1,228,566.26), Jack W Callicutt ($521,835.55), Joel Lewis ($612,080.39), and Khurram Jamil ($1,043,952.19).

Insiders have sold a total of 964,077 Galectin Therapeutics shares in the last 24 months for a total of $4,709,469.85 sold.



This page (NASDAQ:GALT) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners